The CpG-sites of the CBX3 ubiquitous chromatin opening element are critical structural determinants for the anti-silencing function
Abstract Suppression of therapeutic transgene expression from retroviral gene therapy vectors by epigenetic defence mechanisms represents a problem that is particularly encountered in pluripotent stem cells (PSCs) and their differentiated progeny. Transgene expression in these cells, however, can be...
Saved in:
Main Authors: | Jessica Kunkiel, Natascha Gödecke, Mania Ackermann, Dirk Hoffmann, Axel Schambach, Nico Lachmann, Dagmar Wirth, Thomas Moritz |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/39b1333cdd3f49e5b6f13a3b49b6f0d6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Low biological fluctuation of mitochondrial CpG and non-CpG methylation at the single-molecule level
by: Chloe Goldsmith, et al.
Published: (2021) -
CpG-Based Nanovaccines for Cancer Immunotherapy
by: Chen W, et al.
Published: (2021) -
Centromere evolution and CpG methylation during vertebrate speciation
by: Kazuki Ichikawa, et al.
Published: (2017) -
Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system
by: Hanagata N
Published: (2012) -
A CpG island promoter drives the CXXC5 gene expression
by: Pelin Yaşar, et al.
Published: (2021)